welcome to DuchenneXchange
- a positively charged Duchenne muscular dystrophy community.- join today!
- log in
Primary care and emergency department management of the patient with Duchenne muscular dystrophy
source: Pediatrics
year: 2018
authors: Noritz G, Naprawa J, Apkon SD, Kinnett K, Racca F, Vroom E, Birnkrant DJ
summary/abstract:Primary care providers (PCPs) are usually the first point of contact with the health care system for patients with Duchenne muscular dystrophy (DMD), and patients often present to emergency departments in which providers have little experience in dealing with this condition. With this article, we give primary care and emergency medicine providers a background in the common issues that affect people with DMD. By acquiring some specialized knowledge about the multisystem medical complications of DMD and by applying general principles of primary care, such as timely immunization, anticipatory safety counseling, behavioral screening, and routine nutritional and developmental assessments, the PCP can be a valued and effective medical provider to patients with DMD.
The PCP can provide access to and effective coordination among the patient’s specialty caregivers. Moreover, the PCP can become a trusted advisor to the patient and his family about important medical decisions, as well as issues in the psychosocial, behavioral, and educational domains. This article also contains a “pocket guide” used to assess and manage common urgent medical problems that cause patients with DMD to seek care in the emergency department. With the background information discussed in this article, both PCPs and emergency medicine physicians can skillfully care for patients with DMD in their respective settings, optimizing patient outcomes.
organization: Nationwide Children's Hospital, USA; UCSF Benioff Children's Hospital, USA; Seattle Children's Hospital, USA; Parent Project Muscular Dystrophy, USA; Alessandria General Hospital, Italy; Duchenne Parent Project Netherlands, Netherlands; Case Western Reserve University, USADOI: 10.1542/peds.2018-0333K
read more full text source
rareRelated
-
The Muscular Dystrophy AssociationThe Muscular Dystrophy Association is co...
-
Duchenne UK – LinkedInDuchenne UK is a lean, ambitious and hig...
-
Jett FoundationJett Foundation's mission is to increase...
-
Action DuchenneAction Duchenne’s main aim has always ...
-
DMD clinical therapies II: P.135 DMD-HUB: expanding clinical trial capacity for Duchenne muscular dystrophy, 1 year ...The need to increase capacity for Duchen...
-
Duchenne Healthcare Team SpecialistsNeurologist Commonly the head of multi-...
-
Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to strengthen FDA’s expanded access programSince the 1970s, the FDA has helped to f...